ArticleOncoimmunology

Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models.

Daniel Newsted et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.